Synapse - Manjit Bains

Results (28)

Paclitaxel, ifosfamide, and cisplatin as initial salvage chemotherapy for germ cell tumors: Long-term follow-up and outcomes for favorable- and unfavorable-risk disease

Journal Article

Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Bains, M.; Jones, D. R.; Bajorin, D. F.; Bosl, G. J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Outcomes after multidisciplinary management of primary mediastinal germ cell tumors

Journal Article

Caso, R.; Jones, G. D.; Bains, M. S.; Hsu, M.; Tan, K. S.; Feldman, D. R.; Funt, S. A.; Reuter, V. E.; Bosl, G. J.; McHugh, D.; more...
Annals of Surgery (2021)

Fulltext@MSK | Save

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Meeting Abstract

Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Thoracic metastasectomy in germ cell tumor patients treated with first-line versus salvage therapy

Journal Article

Caso, R.; Jones, G. D.; Tan, K. S.; Bosl, G. J.; Funt, S. A.; Sheinfeld, J.; Reuter, V. E.; Amar, D.; Fischer, G.; Molena, D.; more...
Annals of Thoracic Surgery (2021)

Fulltext@MSK | Save

Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)

Meeting Abstract

Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Genetic predictors of response to systemic therapy in esophagogastric cancer

Journal Article

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
Cancer Discovery (2018)

Fulltext@MSK | Save

Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors

Journal Article

Bagrodia, A.; Lee, B. H.; Lee, W.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Pietzak, E. J.; Gao, S. P.; Zabor, E. C.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin efficacy for first-line treatment of patients with intermediate- or poor-risk germ cell tumors

Journal Article

Feldman, D. R.; Hu, J.; Dorff, T. B.; Lim, K.; Patil, S.; Woo, K. M.; Carousso, M.; Hughes, A.; Sheinfeld, J.; Bains, M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors